Having successfully completed clinical trials, Pasadena, NL-based medtech company and Emergence client Swiftsure Innovations has raised a $2.3 million seed funding round, led by Pelorus VC.
Founded three years ago by intensive care unit nurse Deanne McCarthy, Swiftsure is developing medical devices that aim to improve oral care solutions for critically ill patients on ventilator systems. The company is now planning for further trials and to roll out its product in the U.S. market.
As well as Pelorus, which oversees the Venture NL fund, the investors in the round included the all-female funding group Sandpiper Ventures and pan-Canadian consortium MEDTEQ+, as well as others. In November 2021, the company raised a $1.05 million pre-seed round from an investment group that included Threshold Impact, Killick Capital, Pluto Investments, Pelorus and Sandpiper.